Navigation Links
Cambrex Manufacturing Facility Completes Successful US FDA Inspection

EAST RUTHERFORD, N.J., Dec. 16, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") announced that the US Food and Drug Administration (FDA) completed an inspection of Cambrex's active pharmaceutical ingredient (API) manufacturing facility in Charles City, Iowa. The inspection found the site to be compliant with the principles and guidelines of Good Manufacturing Practice (GMP) and no Form 483 observations were issued. The US FDA authorities inspected the facility from July 31 to August 2, 2013.

Joe Nettleton, Vice President Operations and Charles City Site Director commented, "We are very pleased with the results of this latest FDA inspection, which further strengthens our track record of outstanding regulatory compliance. We commit significant resources and work diligently to maintain high quality standards and continuously improve quality platforms within Cambrex."

The entire facility and the quality systems used for the manufacture and release of APIs and food grade products were subject to a detailed compliance inspection. This follows successful inspections at Charles City made previously by the US FDA in March 2010 and February 2012, neither of which resulted in any issued 483 observations, the Korean FDA in January 2012 and the Medicines and Healthcare Products Regulatory Agency (MHRA) of the UK October 2011, after which a GMP certificate for a drug product intermediate was issued.     

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit

SOURCE Cambrex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cambrex to Present at Oppenheimer 24th Annual Healthcare Conference
2. Cambrex To Present At UBS Global Healthcare Conference
3. Cambrex Reschedules Third Quarter 2012 Financial Results and Earnings Call Date to November 5, 2012
4. Cambrex Reports Second Quarter 2012 Results
5. Cambrex to Announce Fourth Quarter 2011 Financial Results on February 6, 2012
6. InstantGMP Completes Updates to v2.03 of their Manufacturing Execution System with Electronic Batch Records
7. New In-Depth Report on Demand and Supply for Contract Manufacturing of Injectable Drugs Through 2019
8. Genesis Herb Company Selects InstantGMP as their Manufacturing Execution System with Electronic Batch Records
9. Pfenex Inc. Awards Paragon Bioservices a Contract for cGMP Manufacturing of its Recombinant Protective Antigen (rPA), for Phase 1 Clinical Trial of its Anthrax Vaccine
10. ACell Expands Indiana Manufacturing Facility to Support Growth
11. Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche
Post Your Comments:
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  Twist Bioscience, a ... Emily Leproust , Ph.D., has been selected as one ... 2015 for fast-tracking the building blocks of life . ... Global Thinkers whose contributions and work have changed lives ... --> "It is an honor to be recognized ...
(Date:12/1/2015)... SAN DIEGO , Dec. 1, 2015 /PRNewswire/ ... that uses allogeneic stem cells for cardiovascular indications, ... clinical trial protocol based on recommendations from a ... leaders and its Scientific Advisory Board members ... boards analyzed preliminary Phase IIa safety and efficacy ...
(Date:12/1/2015)... Cepheid (Nasdaq: CPHD ) today announced ... Jaffray Healthcare Conference in New York City ... its outlook for the fourth quarter of 2015 and ... longer term business model expectations. John Bishop ... to be the fastest growing company of the major ...
(Date:11/30/2015)... ... November 30, 2015 , ... Global ... practitioners and aesthetics professionals from Central America and abroad for the first Iberoamerican ... City, Panama Feb. 17-19, 2016. Testart will present and discuss new trends in ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), the ... entry into the automotive market with a comprehensive and ... of consumer electronics human interface innovation. Synaptics, industry-leading touch ... the automotive industry and will be implemented in numerous ... , Japan , and ...
(Date:10/29/2015)... 29, 2015   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that it ... (MHTA) as one of only three finalists for a ... Small and Growing" category. The Tekne Awards honor ... superior technology innovation and leadership. iMedNet™ ...
Breaking Biology News(10 mins):